Biomarkers Journal Open Access

  • ISSN: 2472-1646
  • Journal h-index: 8
  • Journal CiteScore: 1.05
  • Journal Impact Factor: 0.69
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658
Editorial Panel

Yoshihiro Kikuchi, President
Ooki Memorial Kikuchi Cancer Institue for Women, Saitama, Japan

Michel Herranz, Director of Cyclotron Radiochemistry Centre
Rua Irmans Liste Forjan, Santiago de Compostela, Spain

Jie Du,
Adjunct Associate Professor Department of Internal Medicine Baylor College of Medicine Houston, TX 77030, USA

Read More

Submit Manuscript

Submit manuscript at Online Submission System or send as an e-mail attachment to the Editorial Office at

About the Journal

Biomarkers Journal is an open-access journal and publish the manuscripts after thorough peer review. Biomarkers are referred to as measurable indicators of some biological conditions or severity of disease state. They are useful in a number of ways, including measuring the progress of the disease, evaluating the most effective therapeutic regimens. They are divided into different types based on their characteristics, known as Imaging biomarkers, Diagnostic biomarkers, Molecular biomarkers, etc. Some of them are also used in the pharma industry to know drug optimization in drug development. This journal seeks high quality of journals related to new research of biomarkers and their usage in different fields.

Open access journal is an innovative platform, in which all articles are published online with a rapid review process and anyone in the globe can access it free of charge.

The main aim of this journal is to create the scientific environment on biomarkers research for authors, readers, and upcoming scientists to share their views. Provide the platform for anyone in global to get to know the latest updates on biomarkers research and as well where these can be used.

Submit manuscript at Online Submission System

Fast Editorial Execution and Review Process (FEE-Review Process):

Biomarkers Journal is participating in the Fast Editorial Execution and Review Process (FEE-Review Process) with an additional prepayment of $99 apart from the regular article processing fee. Fast Editorial Execution and Review Process is a special service for the article that enables it to get a faster response in the pre-review stage from the handling editor as well as a review from the reviewer. An author can get a faster response of pre-review maximum in 3 days since submission, and a review process by the reviewer maximum in 5 days, followed by revision/publication in 2 days. If the article gets notified for revision by the handling editor, then it will take another 5 days for external review by the previous reviewer or alternative reviewer.

 Acceptance of manuscripts is driven entirely by handling editorial team considerations and independent peer-review, ensuring the highest standards are maintained no matter the route to regular peer-reviewed publication or a fast editorial review process. The handling editor and the article contributor are responsible for adhering to scientific standards. The article FEE-Review process of $99 will not be refunded even if the article is rejected or withdrawn for publication.

The corresponding author or institution/organization is responsible for making the manuscript FEE-Review Process payment. The additional FEE-Review Process payment covers the fast review processing and quick editorial decisions, and regular article publication covers the preparation in various formats for online publication, securing full-text inclusion in a number of permanent archives like HTML, XML, and PDF, and feeding to different indexing agencies.


Articles published in Biomarkers Journal have been cited by esteemed scholars and scientists all around the world. Biomarkers Journal has got h-index 8 , which means every article in Biomarkers Journal has got 8 average citations.

Journal Highlights

Current Issue Highlights

0.329+ Million Readerbase
Share This Page
Recommended Webinars & Conferences